APP and Alzheimer disease: The hyperlocomotion shown by APP/PS1 mice in the open field test corroborates previous studies (Hooijmans et al., 2009; Cheng et al., 2014), and has been associated with agitation and increased locomotor activity observed in patients with AD (Chung and Cummings, 2000).